Mohamed Refaat is a seasoned pharmaceutical professional with extensive experience in cardiovascular interventions and therapeutic management. From September 2017 to February 2019, Mohamed worked as a Product Specialist at Sandoz, focusing on cardiometabolic issues. From March 2019 to December 2024, Mohamed held the position of Executive ACS-Heart Failure Specialist at AstraZeneca, excelling in the management of Acute Coronary Syndrome patients and overseeing the use of ticagrelor therapy. Previously, Mohamed served as a Medical Representative specializing in hypertension at MSD and held various leadership roles, including President of the Pharma Student Organization and Professional Development Chairperson at CUPSSA - EPSF. Mohamed began the professional journey with a Bachelor of Pharmacy degree from Ahram Canadian University, completed in 2013.
This person is not in the org chart
This person is not in any teams
This person is not in any offices